News Gelesis Holdings, Inc. Nyse

Equities

CPSR

US36850R2040

Market Closed - Nyse Other stock markets 10:04:16 2024-03-20 am EDT			5-day change	1st Jan Change
0.0198 ^USD	+1,979,900.00%		+1,299,900.00%	-99.61%

Apr. 19	Bidding Procedure Approved for Gelesis Holdings, Inc.	CI
Apr. 09	Motion for Asset Sale Filed by Gelesis Holdings, Inc.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bidding Procedure Approved for Gelesis Holdings, Inc.	Apr. 19	CI
Motion for Asset Sale Filed by Gelesis Holdings, Inc.	Apr. 09	CI
Motion for Joint Administration Approved for Gelesis Holdings, Inc.	Feb. 01	CI
Motion for Joint Administration Filed by Gelesis Holdings, Inc.	Jan. 30	CI
Gelesis Holdings Provides Information to Shareholders	23-10-31	CI
Gelesis : Bankruptcy - Form 8-K	23-10-31	PU
Gelesis Holdings, Inc. Filed for Bankruptcy	23-10-30	CI
PureTech Health plc cancelled the acquisition of the remaining 76.7% stake in Gelesis Holdings, Inc. from Pacific Investment Management Company LLC, Hpso Spv Limited, SSD2 LLC, Cms Medical Venture Investment (HK) Limited and others.	23-10-11	CI
Gelesis Holdings, Inc. Appoints Mr. Yishai Zohar as Interim Principal Financial Officer	23-08-21	CI
Gelesis Holdings, Inc. Appoints Mr. Yishai Zohar as Chief Compliance Officer, Corporate Secretary, Treasurer, Principal Accounting Officer	23-08-21	CI
Gelesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Orgenesis Names Elliot Maltz Chief Financial Officer	23-07-13	MT
Elliot Maltz, the Chief Financial Officer of Gelesis Holdings, Inc. Resigns, Effective August 15, 2023	23-07-12	CI
Elliot Maltz, Treasurer, Chief Compliance Officer and Corporate Secretary (And Principal Financial and Accounting Officer) of Gelesis Holdings, Inc. Resigns from All Positions, Effective August 15, 2023	23-07-12	CI
Gelesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Gelesis Holdings, Inc. announced that it has received $2 million in funding from PureTech Health LLC	23-04-30	CI
Gelesis Holdings, Inc. Announces Board Changes	23-04-21	CI
Gelesis Holdings, Inc. Announces Resignation of Dominic Perks as Class I Director	23-04-17	CI
Gelesis Holdings, Inc.(OTCPK:GLSH) dropped from S&P TMI Index	23-04-14	CI
GELESIS HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-04-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Gelesis Holdings, Inc. Nyse

Equities

CPSR

US36850R2040

Summary

Filters